ArticleCureus2025
Clinical Outcomes of Patients Managed in a Temporary COVID-19 Step-Down Unit.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background During the coronavirus disease 2019 (COVID-19) pandemic, unprecedented surges of patients strained healthcare resources, especially intensive care units (ICUs), which were quickly saturated by patients with respiratory failure. To inform future responses, we conducted a retrospective analysis of patient outcome data from a temporary COVID-19 transitional care/step-down unit (TCU) we implemented during January-February 2021. Methods Our TCU was embedded on a medical-surgical floor at our academic hospital institution to offload ICU patients with stable or improving respiratory failure, who still required heated humidified high-flow nasal cannula (HHHFNC) and/or noninvasive positive pressure ventilation (NIPPV). Our Hospital Medicine and Critical Care service lines devised specific clinical criteria for patient selection to the unit. We recruited personnel with experience in HHHFNC and NIPPV and ensured that a physician or Advanced Practice Provider was virtually always physically present on the unit. We performed descriptive statistical analysis of patient outcomes (disposition, length of stay, and readmission) and demographic characteristics (age, sex, and baseline comorbidities). Results Twenty-six patients were treated in the COVID-19 TCU. At baseline, patients had a mean of 2.8 comorbidities per person (range: 0-7, median 3). Eight patients (31%) were female and 18 (69%) were male. The mean age of the patients was 70.9 years (range: 32-94 years, median 70.5). Five (19.2%) were downgraded to the general medical ward, 17 (65.4%) were discharged to home or another medical facility in good condition, and four (15.4%) were provided comfort care (one died awaiting transport to hospice). The mean TCU length of stay was 7.6 days, and the mean hospital length of stay was 16 days. Only one patient required readmission within one month. No patients experienced unexpected cardiopulmonary arrest or required transfer back to the ICU. Conclusions Our TCU, embedded within a medical-surgical floor, effectively and safely liberated ICU beds during a pandemic. Using agreed-upon clinical criteria for appropriate transfer to the TCU and appropriate staffing, we conserved critical care resources and improved patient flow without major adverse events or ICU readmissions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.